Paraneoplastic neurological syndromes associated with ovarian tumors. 2015

Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
Division of Gynecologic Oncology, Department of Gynecology, Obstetrics and Gynecologic Oncology, Poznan University of Medical Sciences, Polna str. 33, 60-535, Poznan, Poland, mikolaj.zaborowski@gmail.com.

BACKGROUND Paraneoplastic neurological syndromes (PNS) are neurologic deficits triggered by an underlying remote tumor. PNS can antedate clinical manifestation of ovarian malignancy and enable its diagnosis at an early stage. Interestingly, neoplasms associated with PNS are less advanced and metastasize less commonly than those without PNS. This suggests that PNS may be associated with a naturally occurring antitumor response. METHODS We review the literature on the diagnosis, pathogenesis and management of PNS associated with ovarian tumors: paraneoplastic cerebellar degeneration (PCD) and anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis. An approach to the diagnostic workup of underlying tumors is discussed. RESULTS PCD can precede the manifestation of ovarian carcinoma. Anti-NMDAR encephalitis in young women appears often as a result of ovarian teratoma. Since ovarian tumors and nervous tissue share common antigens (e.g., cdr2, NMDAR), autoimmune etiology is a probable mechanism of these neurologic disorders. The concept of cross-presentation, however, seems insufficient to explain entirely the emergence of PNS. Early resection of ovarian tumors is a significant part of PNS management and improves the outcome. CONCLUSIONS The diagnosis of PNS potentially associated with ovarian tumor indicates a need for a thorough diagnostic procedure in search of the neoplasm. In some patients, explorative laparoscopy/laparotomy can be considered.

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010257 Paraneoplastic Syndromes In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products. Paraneoplastic Syndrome,Syndrome, Paraneoplastic,Syndromes, Paraneoplastic
D011044 Poland A country in central Europe, east of Germany. The capital is Warsaw. Polish People's Republic,Republic of Poland
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
November 1994, Leukemia & lymphoma,
Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
January 2022, Frontiers in oncology,
Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
February 1999, Archives of neurology,
Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
February 1999, Archives of neurology,
Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
March 2014, Brain & development,
Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
January 1996, Springer seminars in immunopathology,
Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
November 2002, The Lancet. Neurology,
Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
December 2008, The Ceylon medical journal,
Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
October 2007, Presse medicale (Paris, France : 1983),
Mikolaj Piotr Zaborowski, and Marek Spaczynski, and Ewa Nowak-Markwitz, and Slawomir Michalak
January 2002, Duodecim; laaketieteellinen aikakauskirja,
Copied contents to your clipboard!